Live Ventures' Diverse Portfolio Is Its Ultimate Superpower (NASDAQ:LIVE) — Neutral
LIVE Accesswire — September 17, 2025LAS VEGAS, NV / ACCESS Newswire / September 17, 2025 / Live Ventures (NASDAQ:LIVE) isn't the kind of company that waits around for Wall Street to hand it a narrative. It writes its own.
FirstService Expands Commercial Roofing Geographic Footprint in Key Markets — Neutral
FSV GlobeNewsWire — September 17, 2025Roofing Corp of America Acquires Florida-Based Springer-Peterson and California-Based A-1 All American Roofing Corp of America Acquires Florida-Based Springer-Peterson and California-Based A-1 All American
PAR® Technology Launches PAR Games™: The Loyalty Game-Changer Brands Have Been Waiting For — Neutral
PAR Business Wire — September 17, 2025NEW HARTFORD, N.Y.--(BUSINESS WIRE)--PAR Technology Corporation (NYSE: PAR), a leading foodservice technology provider, today announced the launch of PAR Games™, an interactive loyalty experience designed to engage guests through fun, personalized brand moments triggered by everyday behaviors. By transforming passive loyalty into real-time, emotional engagement, PAR Games helps marketers drive visits, capture zero-party data, and reward guests—without over-relying on discounts. Loyalty programs.
HOUSTON--(BUSINESS WIRE)--HPE (NYSE: HPE) will host its Securities Analyst Meeting on October 15, 2025. Join a live webcast to hear featured presentations from Antonio Neri, president and CEO; Marie Myers, executive vice president and CFO; and Rami Rahim, executive vice president, president and general manager, HPE Networking, as they review the company's strategy and long-term financial outlook. The webcast will begin Wednesday, October 15, at 2:00 p.m. CT (3:00 p.m. ET) and will be available.
Kinectrics Significantly Increases Isotope Production Capacity to Meet Growing Global Demand — Neutral
BWXT Business Wire — September 17, 2025TORONTO--(BUSINESS WIRE)--Kinectrics, a division of BWX Technologies Inc. (NYSE: BWXT), announced today the completion of a major expansion to its isotope production capabilities, reinforcing its role as a global supplier of highly enriched stable isotopes and establishing the only North American source for Yb-176, reducing the reliance on foreign material for life-saving cancer treatments. Kinectrics commissioned four new 2nd generation Electromagnetic Isotope Separator (EMIS) units, which wil.
Award-Winning Landmark Group Joins The Real Brokerage, Bringing 250 Agents and a Legacy of Service — Neutral
REAX Business Wire — September 17, 2025MIAMI--(BUSINESS WIRE)---- $REAX #therealbrokerage--Landmark Group with 250 agents joins The Real Brokerage, bringing its legacy of service and fueling Mid-Atlantic growth.
Flowserve Announces the Appointment of Alice DeBiasio as President of Flow Control Division — Neutral
FLS Business Wire — September 17, 2025DALLAS--(BUSINESS WIRE)--Flowserve Corporation (NYSE: FLS) (“Flowserve”), a leading provider of flow control products and services for the global infrastructure markets, has announced that Alice DeBiasio will join the company as President of the Flow Control Division, beginning Monday, Oct. 13, 2025. Alice DeBiasio is an accomplished leader with extensive experience leading global industrial organizations and driving consistent profitable growth, innovation and customer loyalty. Most recently,.
PGIM and Partners Group enter strategic partnership to deliver multi-asset solutions — Neutral
PRU Business Wire — September 17, 2025NEWARK, N.J.--(BUSINESS WIRE)--Partnership combines PGIM's expertise across public and private asset classes with Partners Group's track record in private equity and infrastructure.
State Street Elects Brian Porter to its Board of Directors — Neutral
STT Business Wire — September 17, 2025BOSTON--(BUSINESS WIRE)--State Street Corporation (NYSE: STT) today announced the election of Brian Porter to its Board of Directors. Mr. Porter, age 67, has more than forty years' experience in banking and serving institutional clients, including expertise in international banking, risk management, corporate banking, and capital markets. Mr. Porter formerly served as President and Chief Executive Officer of The Bank of Nova Scotia (Scotiabank), which reported total revenues approaching CAD 32.
NASHVILLE, Tenn. , Sept. 17, 2025 /PRNewswire/ -- AllianceBernstein Holding L.P.
Capstone Builds the Industry's Most Efficient Integration Process — Neutral
CAPS Accesswire — September 17, 2025Integration Strategy Makes Acquisitions Accretive from Day One, Delivering Value to Customers and Shareholders NEW YORK CITY, NY / ACCESS Newswire / September 17, 2025 / Capstone Holding Corp. (NASDAQ:CAPS), a national building products distribution platform, today published a new article on how it has built the industry's most seamless integration process. Key Highlights: Integration as a Value Driver: Capstone's integration process makes acquisitions accretive from day one, delivering immediate value for customers and shareholders.
Dime Continues to Execute on Growth Plan With Commercial Lending Expansion — Neutral
DCOM GlobeNewsWire — September 17, 2025HAUPPAUGE, N.Y., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced the expansion of its commercial lending platform with the addition of several seasoned banking professionals.
CervoMed Highlights Neflamapimod's Potential Benefits in Session on Dementia with Lewy Bodies at the 150th Annual American Neurology Association Conference — Neutral
CRVO GlobeNewsWire — September 17, 2025BOSTON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that the promising development program and potential benefits of neflamapimod for the treatment of Dementia with Lewy Bodies (DLB) were highlighted in a presentation on advances in DLB drug development by Dr. James Galvin at the 150th Annual American Neurological Association (ANA) conference held September 13-16, 2025 in Baltimore, Maryland.
Caliber Announces Sale of $15.9 Million Perpetual Convertible Preferred and Activation of ATM Program — Neutral
CWD GlobeNewsWire — September 17, 2025Access to additional capital further strengthens Digital Asset Treasury execution strategy Preferred converts to common stock at $250 per Caliber share SCOTTSDALE, Ariz., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Caliber (NASDAQ: CWD), a diversified real estate and digital asset management platform, today announced that it has closed a securities purchase agreement with an institutional investor for the sale of $15.9 million of perpetual convertible preferred equity and, separately, has established and activated an At-The-Market (ATM) equity program.
nCino Introduces Integration Gateway to Streamline Data Connectivity for Financial Institutions and Fintech Partners — Neutral
NCNO GlobeNewsWire — September 17, 2025nCino Integration Gateway delivers a purpose-built bridge for financial institutions and their fintech partners to innovate faster, reduce costs, and scale at speed nCino Integration Gateway delivers a purpose-built bridge for financial institutions and their fintech partners to innovate faster, reduce costs, and scale at speed
Palvella Therapeutics Announces Scientific Publication in Lymphatic Research and Biology Highlighting Recent Advances in the Pathogenesis of Venous Malformations and the Real-World Use of Rapamycin as an Emerging Targeted Therapy — Neutral
PVLA GlobeNewsWire — September 17, 2025Recent advances in understanding venous malformation disease pathogenesis highlight the PI3K/AKT/mTOR pathway as a key driver of disease proliferation, spurring real-world off-label use of systemic rapamycin (sirolimus) Publication includes a systematic review of 26 studies evaluating the use of rapamycin for the treatment of venous malformations Study authors highlight unmet clinical need for venous malformations and lack of FDA-approved pharmacologic options while advocating for an FDA-approved targeted topical formulation of rapamycin for patients with cutaneous venous malformations WAYNE, Pa., Sept. 17, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing …
Rein Therapeutics Announces Publication of New Translational Data in iScience on Company's Novel Therapy for Idiopathic Pulmonary Fibrosis — Neutral
RNTX GlobeNewsWire — September 17, 2025AUSTIN, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced the publication of novel data on its lead drug candidate, LTI-03, in iScience, a peer-reviewed, open-access journal published by Cell Press.
Pine Ridge Uranium Project Delivers Excellent Initial Drill Results — Neutral
LITM Newsfile Corp — September 17, 2025Winnipeg, Manitoba--(Newsfile Corp. - September 17, 2025) - Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) ("Snow Lake"), a uranium exploration and development company, announces excellent initial drill results on its Pine Ridge Uranium Project ("Pine Ridge"), located in the prolific Powder River Basin in Wyoming, a 50/50 joint venture (the "Joint Venture") with Global Uranium and Enrichment Limited ("GUE").
Tesla Stock Drops After 6-Day Winning Streak. Why the Fed's Rate Call Matters. — Negative
TSLA Barrons — September 17, 2025Coming into Wednesday trading, Tesla stock has risen for six consecutive trading sessions, gaining about 22% in the process.
Regeneron's bone disorder treatment succeeds in late-stage trial — Positive
REGN Reuters — September 17, 2025Regeneron Pharmaceuticals said on Wednesday its experimental treatment for a rare genetic disorder that affects bone tissue has met the main goal of a late-stage trial.